Ways2Well Selects Cancer Check Labs as its Provider of Early Cancer Detection Test
Cancer Check Labs has been chosen as the exclusive provider of early cancer detection tests for Ways2Well, a regenerative medicine clinic.
Read MorePosted by Andy Lundin | Aug 16, 2024 | Unknown Origin & Other Cancer Types |
Cancer Check Labs has been chosen as the exclusive provider of early cancer detection tests for Ways2Well, a regenerative medicine clinic.
Read MorePosted by Chris Wolski | Aug 7, 2024 | Respiratory Disease |
A new study has found that a blood test can predict which preterm babies will develop chronic lung disease, allowing for earlier diagnosis.
Read MorePosted by Chris Wolski | Aug 5, 2024 | Molecular Diagnostic Analyzers |
Indica Labs’ Lung Macrodissect AI, an AI-powered tool designed to enhance slide macrodissection and molecular pathology workflows.
Read MorePosted by Andy Lundin | Jul 29, 2024 | Lung Cancer |
A new study from OncoHost reveals that its PROphetNSCLC test impacts oncologists’ first-line treatment decisions for metastatic NSCLC.
Read MorePosted by Chris Wolski | Jul 24, 2024 | Analytical Software Systems |
Proscia has launched an updated version of Concentriq AP, enhancing AI-enabled pathology workflows to improve understanding of major cancers.
Read More